Isolation and Characterization of a Novel ConusPeptide with Apparent Antinociceptive Activity*
暂无分享,去创建一个
D. Yoshikami | J. McIntosh | G. Bulaj | B. Olivera | R. Layer | J. Garrett | L. Cruz | A. Vyazovkina | J. Wagstaff | R. Layer | G. Corpuz | Gloria Corpuz
[1] B. Olivera,et al. Conotoxins, in retrospect. , 2001, Toxicon : official journal of the International Society on Toxinology.
[2] R M Jones,et al. Conotoxins - new vistas for peptide therapeutics. , 2000, Current pharmaceutical design.
[3] D. Yoshikami,et al. Conus peptides: novel probes for nicotinic acetylcholine receptor structure and function. , 2000, European journal of pharmacology.
[4] B. Olivera,et al. The T-superfamily of Conotoxins* , 1999, The Journal of Biological Chemistry.
[5] J. McIntosh,et al. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. , 1999, Annual review of biochemistry.
[6] B. Olivera,et al. Contulakin-G, an O-Glycosylated Invertebrate Neurotensin* , 1999, The Journal of Biological Chemistry.
[7] P. Fossier,et al. A conotoxin from Conus textile with unusual posttranslational modifications reduces presynaptic Ca2+ influx. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[8] David J. Craik,et al. Conotoxins and their potential pharmaceutical applications , 1999 .
[9] J. McIntosh,et al. Conus peptides as probes for ion channels. , 1999, Methods in enzymology.
[10] D. Yoshikami,et al. An O-glycosylated neuroexcitatory conus peptide. , 1998, Biochemistry.
[11] D. Yoshikami,et al. α-Conotoxin AuIB Selectively Blocks α3β4 Nicotinic Acetylcholine Receptors and Nicotine-Evoked Norepinephrine Release , 1998, The Journal of Neuroscience.
[12] A. C. Collins,et al. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. , 1998, The Journal of pharmacology and experimental therapeutics.
[13] Y. Terada,et al. Tetrodotoxin-resistant Na+ spikes of C fibers have at least two subtypes in the isolated bullfrog sciatic nerve , 1996, Neuroscience Letters.
[14] J. Elliott,et al. Differential effects of tetrodotoxin (TTX) and high external K+ on A and C fibre compound action potential peaks in frog sciatic nerve , 1996, Neuroscience Letters.
[15] Walter Stühmer,et al. Strategy for rapid immobilization of prey by a fish-hunting marine snail , 1996, Nature.
[16] M. Spira,et al. A New Family of Conotoxins That Blocks Voltage-gated Sodium Channels (*) , 1995, The Journal of Biological Chemistry.
[17] W. Gray. Disulfide structures of highly bridged peptides: A new strategy for analysis , 1993, Protein science : a publication of the Protein Society.
[18] P. Soubrié,et al. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Kleinman,et al. Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences , 1992, Peptides.
[20] B. Bean,et al. A new conus peptide ligand for mammalian presynaptic Ca2+ channels , 1992, Neuron.
[21] P. Portoghese,et al. delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites. , 1992, European journal of pharmacology.
[22] G. Pasternak,et al. Evidence for κ1 opioid receptor multiplicity in the guinea pig cerebellum , 1991 .
[23] K. Kellar,et al. [3H]cytisine binding to nicotinic cholinergic receptors in brain. , 1991, Molecular pharmacology.
[24] J. Schwartz,et al. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates , 1990, Brain Research.
[25] Gavin Kilpatrick,et al. Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cells. , 1990, European journal of pharmacology.
[26] R. Leurs,et al. Histamine receptors: subclasses and specific ligands. , 1990, Pharmacology & therapeutics.
[27] M. Tabaton,et al. Adrenergic Receptors in Aging and Alzheimer's Disease: Increased β2‐Receptors in Prefrontal Cortex and Hippocampus , 1989, Journal of neurochemistry.
[28] R. Spealman,et al. Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane. , 1989, Molecular pharmacology.
[29] A. Goldstein,et al. Multiple opioid receptors: ligand selectivity profiles and binding site signatures. , 1989, Molecular pharmacology.
[30] M. Garcia-Calvo,et al. Thermodynamics of Agonist and Antagonist Interaction with the Strychnine‐Sensitive Glycine Receptor , 1989, Journal of neurochemistry.
[31] C. Sinton,et al. CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. , 1988, The Journal of pharmacology and experimental therapeutics.
[32] D. Hoyer,et al. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding. , 1988, Molecular pharmacology.
[33] S. Snyder,et al. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. , 1987, The Journal of pharmacology and experimental therapeutics.
[34] M. Williams,et al. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors. , 1987, The Journal of pharmacology and experimental therapeutics.
[35] P. Krogsgaard‐Larsen,et al. Comparative stereostructure-activity studies on GABAA and GABAB receptor sites and GABA uptake using rat brain membrane preparations. , 2006, Journal of neurochemistry.
[36] B. Olivera,et al. Calcium channel antagonists. Omega-conotoxin defines a new high affinity site. , 1986, The Journal of biological chemistry.
[37] M. Worcel,et al. The effects of some slow channel blocking drugs on high affinity serotonin uptake by rat brain synaptosomes. , 1986, European journal of pharmacology.
[38] V. Hruby,et al. Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15). , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Mccall,et al. [3H]U-69593 a highly selective ligand for the opioid κ receptor , 1985 .
[40] J. McIntosh,et al. Gamma-carboxyglutamate in a neuroactive toxin. , 1984, The Journal of biological chemistry.
[41] B. Wolfe,et al. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. , 1984, Molecular pharmacology.
[42] S. Snyder,et al. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. , 1984, Molecular pharmacology.
[43] P. Emson,et al. Specific binding of triatiated neurotensin to rat brain membranes: Characterization and regional distribution , 1984, Brain Research.
[44] B. Wolfe,et al. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. , 1984, The Journal of pharmacology and experimental therapeutics.
[45] J. Dodd,et al. A reclassification of B and C neurones in the ninth and tenth paravertebral sympathetic ganglia of the bullfrog. , 1983, The Journal of physiology.
[46] H. Kosterlitz,et al. SPECTRUM OF THE μ‐, δ‐ AND κ‐BINDING SITES IN HOMOGENATES OF RAT BRAIN , 1982 .
[47] M. Briley,et al. High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline. , 1982, European journal of pharmacology.
[48] H. Y. Kwa,et al. Identical antagonist selectivity of central and peripheral alpha 1-adrenoceptors. , 1981, Molecular pharmacology.
[49] M. Briley,et al. High-affinity [3H] DMI binding is associated with neuronal noradrenaline uptake in the periphery and the central nervous system. , 1981, European journal of pharmacology.
[50] B. Olivera,et al. A toxin from the venom of the marine snail Conus geographus which acts on the vertebrate central nervous system. , 1981, Toxicon : official journal of the International Society on Toxinology.
[51] G. Wilcox,et al. Intrathecal morphine in mice: a new technique. , 1980, European journal of pharmacology.
[52] W. Catterall. Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. , 1980, Annual review of pharmacology and toxicology.
[53] P. Molinoff,et al. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. , 1979, Molecular pharmacology.
[54] S. Snyder,et al. HETEROGENEITY OF HISTAMINE Hi‐RECEPTORS: SPECIES VARIATIONS IN [3H]MEPYRAMINE BINDING OF BRAIN MEMBRANES , 1979, Journal of neurochemistry.
[55] S. Snyder,et al. Stereospecificity and structure-activity requirements of GABA receptor binding in rat brain , 1977, Brain Research.
[56] S. Snyder,et al. Strychnine Binding in Rat Spinal Cord Membranes Associated with the Synaptic Glycine Receptor: Cooperativity of Glycine Interactions , 1974 .
[57] S. Snyder,et al. Muscarinic cholinergic binding in rat brain. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[58] A. McComas,et al. Electrical signs of nervous activity , 1971 .
[59] A. Ecker,et al. [Anatomy of the frog]. , 1964, Sistole.